EO

Eliot Ohlstein

VT Velicept Therapeutics: 6 patents #1 of 7Top 15%
VT Vtv Therapeutics: 4 patents #17 of 50Top 35%
BO BOE: 4 patents #4,064 of 12,373Top 35%
SB Smithkline Beckman: 3 patents #37 of 166Top 25%
SL Smithkline Beecham Limited: 1 patents #893 of 1,624Top 55%
📍 Glenmoore, PA: #7 of 91 inventorsTop 8%
🗺 Pennsylvania: #3,862 of 74,527 inventorsTop 6%
Overall (All Time): #253,906 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
11096946 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Maria Carmen Valcarce Lopez 2021-08-24
10751311 Compositions and methods of using modified release solabegron for lower urinary tract symptoms Raymond E. STEVENS, H. Jeffrey Wilkins 2020-08-25
10668034 Pharmaceutical compositions and the treatment of overactive bladder Stephen Caltabiano, Stewart McCallum 2020-06-02
10456406 Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Maria Carmen Valcarce Lopez 2019-10-29
10350182 Pharmaceutical compositions and the treatment of overactive bladder Stephen Caltabiano, Stewart McCallum 2019-07-16
9968613 Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb Maria Carmen Valcarce Lopez 2018-05-15
9956194 Compositions and methods of using modified release solabegron for lower urinary tract symptoms Raymond E. STEVENS, H. Jeffrey Wilkins 2018-05-01
9907767 Pharmaceutical compositions and the treatment of overactive bladder Stephen Caltabiano, Stewart McCallum 2018-03-06
9522129 Pharmaceutical Combination Stephen Caltabiano, Stewart McCallum 2016-12-20
9487493 Use of a PPAR-delta agonist for treating muscle atrophy Maria Carmen Valcarce Lopez 2016-11-08
8642661 Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists Stephen Caltabiano, Stewart McCallum 2014-02-04
5643939 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation 1997-07-01
5453436 Treatment of athereosclerosis using, carbazolyl-(4)-oxypropanolamine compounds 1995-09-26
5393772 Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation Tian-Li Yue, Giora Feuerstein 1995-02-28
5308862 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation 1994-05-03
4935438 Dopamine-.beta.-hydroxylase inhibitors Lawrence I. Kruse, Stephen T. Ross 1990-06-19
4912226 Intermediate to dopamine-.beta.-hydroxylase inhibitors Lawrence I. Kruse, Stephen T. Ross 1990-03-27
4882348 2-(aminoalkylthio)imidazoles as dopamine-.beta.-hydroxylase inhibitors Lawrence I. Kruse, Stephen T. Ross 1989-11-21